News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 4, 2011

Detrusor Instability

Author(s)Ahmed Walid Anwar Murad, MD

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

David Shalowitz, MD, on cross-specialty collaboration to expand salpingectomy access

David Shalowitz, MD, on cross-specialty collaboration to expand salpingectomy access

ByDavid I. Shalowitz, MD, MSHP

September 8th 2026

David Shalowitz, MD, on strengthened evidence behind salpingectomy for ovarian cancer prevention

David Shalowitz, MD, on strengthened evidence behind salpingectomy for ovarian cancer prevention

ByDavid I. Shalowitz, MD, MSHP

September 3rd 2026

Top headlines in women's health from August 2026

Top headlines in women's health from August 2026

ByContemporary OB/GYN Staff

September 1st 2026

ACOG clinical update recommends salpingectomy at time of hysterectomy | image credit: stock.adobe.com

ACOG clinical update recommends salpingectomy at time of hysterectomy

ByContemporary OB/GYN Staff

August 26th 2026

Using a self-collected vaginal fluid test for endometrial cancer detection

Using a self-collected vaginal fluid test for endometrial cancer detection

ByElle Kielar Grevstad, PhD

June 22nd 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

Amber Watters, MD, on emergency preparedness and building a version program

New tool translates pregnancy test research into individualized patient counseling resource